How to Achieve High-Quality Oocytes? The Key Role of Myo-Inositol and Melatonin

International Journal of Endocrinology

Volumn 2016, Issue , 2016, Pages

  Vitale, Salvatore Giovanni ^a   Rossetti, Paola ^b   Corrado, Francesco ^a   Rapisarda, Agnese Maria Chiara ^c   La Vignera, Sandro ^d   Condorelli, Rosita Angela ^d   Valenti, Gaetano ^c   Sapia, Fabrizio ^c   Laganà, Antonio Simone ^a   Buscema, Massimo ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Cannizzaro Emergency Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALICYCLIC HYDROXY COMPOUND; ALPHA TOCOPHEROL; DEXTRO CHIRO INOSITOL; FOLIC ACID; INOSITOL; MELATONIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; FEMALE GENITAL TRACT PARAMETERS; FERTILIZATION; HUMAN; IN VITRO FERTILIZATION; INTRACELLULAR SIGNALING; NONHUMAN; OOCYTE; OOCYTE MATURATION; OOCYTE QUALITY; OVULATION; OXIDATIVE STRESS; PREGNANCY RATE; REVIEW; STEREOISOMERISM;

EID: 84987909289     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2016/4987436     Document Type: Review

References (75)

1. Practice Committee of American Society for Reproductive Medicine, "Definitions of infertility and recurrent pregnancy loss: a committee opinion," Fertility and Sterility, vol. 99, no. 1, p. 63, 2013.
2. A. Chandra, C. E. Copen, and E. H. Stephen, "Infertility and impaired fecundity in the United States, 1982-2010: data from the National Survey of Family growth," National Health Statistics Reports 67, National Center for Health Statistics, Hyattsville, Md, USA, 2013.
3. M. E. Thoma, A. C. McLain, J. F. Louis et al., "Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach," Fertility and Sterility, vol. 99, no. 5, pp. 1324-1331.e1, 2013.
4. S. J. Ventura, "Trend and variation in first births to older women. United States 1970-86," Vital and Health Statistics, vol. 21, pp. 1-27, 1989.
5. B. E. Hamilton, J. A. Martin, and S. J. Ventura, "Births: preliminary data for 2010," National Vital Statistics Reports, vol. 60, pp. 1-25, 2011.
6. D. T. Baird, J. Collins, J. Egozcue et al., "Fertility and ageing," Human Reproduction Update, vol. 11, no. 3, pp. 261-276, 2005.
7. J. Menken, J. Trussell, and U. Larsen, "Age and infertility," Science, vol. 233, no. 4771, pp. 1389-1394, 1986.
8. D. T. Baird, J. Collins, J. Egozcue et al., "Fertility and ageing," Human Reproduction Update, vol. 11, no. 3, pp. 261-267, 2005.
9. U. Eichenlaub-Ritter, E. Vogt, H. Yin, and R. Gosden, "Spindles, mitochondria and redox potential in ageing oocytes," Reproductive BioMedicine Online, vol. 8, no. 1, pp. 45-58, 2004.
10. J. Wang and M. V. Sauer, "In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technological advancement," Therapeutics and Clinical Risk Management, vol. 2, no. 4, pp. 355-364, 2006.
11. P. C. Steptoe and R. G. Edwards, "Birth after the reimplantation of a human embryo," The Lancet, vol. 2, no. 8085, p. 366, 1978.
12. P. Lutjen, A. Trounson, J. Leeton, J. Findlay, C. Wood, and P. Renou, "The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure," Nature, vol. 307, no. 5947, pp. 174-175, 1984.
13. CDC-National Center for Chronic Disease Prevention and Health Promotion, "Assisted reproductive technology success rates. National summary and fertility clinic reports (online)," http://www.cdc.gov/art/pdf/2013-report/art-2013-fertility-clinic-report.pdf.
14. M. Wikland, L. Enk, K. Hammarberg, and L. Nilsson, "Use of a vaginal transducer for oocyte retrieval in an IVF/ET program," Journal of Clinical Ultrasound, vol. 15, no. 4, pp. 245-251, 1987.
15. G. Palermo, H. Joris, P. Devroey, and A. C. Van Steirteghem, "Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte," The Lancet, vol. 340, no. 8810, pp. 17-18, 1992.
16. D. M. Miller, G. R. Buettner, and S. D. Aust, "Transition metals as catalysts of 'autoxidation' reactions," Free Radical Biology and Medicine, vol. 8, no. 1, pp. 95-108, 1990.
17. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease," International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
18. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, "Free radicals, metals and antioxidants in oxidative stressinduced cancer," Chemico-Biological Interactions, vol. 160, no. 1, pp. 1-40, 2006.
19. N. Sugino, "Reactive oxygen species in ovarian physiology," Reproductive Medicine and Biology, vol. 4, no. 1, pp. 31-44, 2005.
20. L. L. Espey, "Ovulation as an inflammatory reaction: a hypothesis," Biology of Reproduction, vol. 22, no. 1, pp. 73-106, 1980.
21. Y. Nakamura, H. Tamura, H. Takayama, and H. Kato, "Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production," Fertility and Sterility, vol. 80, no. 4, pp. 1012-1016, 2003.
22. H. Tamura, Y. Nakamura, A. Korkmaz et al., "Melatonin and the ovary: physiological and pathophysiological implications," Fertility and Sterility, vol. 92, no. 1, pp. 328-343, 2009.
23. T. Paszkowski, A. I. Traub, S. Y. Robinson, and D. McMaster, "Seleniumdependent glutathione peroxidase activity in human follicular fluid," Clinica Chimica Acta, vol. 236, no. 2, pp. 173-180, 1995.
24. D. X. Tan, L. D. Chen, B. Poeggeler, L. C. Manchester, and R. J. Reiter, "Melatonin: a potent, endogenous hydroxyl radical scavenger," Endocrine Journal, vol. 1, pp. 57-60, 1993.
25. R. J. Reiter and R. J. Hester, "Interrelationships of the pineal gland, the superior cervical ganglia and the photoperiod in the regulation of the endocrine systems of hamsters," Endocrinology, vol. 79, no. 6, pp. 1168-1170, 1966.
26. S. F. Pang, L. Li, E. A. Ayre et al., "Neuroendocrinology of melatonin in reproduction: recent developments," Journal of Chemical Neuroanatomy, vol. 14, no. 3-4, pp. 157-166, 1998.
27. D. Acuña-Castroviejo, G. Escames, C. Venegas et al., "Extrapineal melatonin: sources, regulation, and potential functions," Cellular and Molecular Life Sciences, vol. 71, no. 16, pp. 2997-3025, 2014.
28. H. Tamura, A. Takasaki, T. Taketani et al., "The role of melatonin as an antioxidant in the follicle," Journal of Ovarian Research, vol. 26, article 5, 2012.
29. 2 melatonin receptors in mammals," Endocrine, vol. 27, no. 2, pp. 101-110, 2005.
30. D.-X. Tan, L. C. Manchester, R. J. Reiter, W.-B. Qi, M. Karbownik, and J. R. Calvo, "Significance of melatonin in antioxidative defense system: reactions and products," Biological Signals and Receptors, vol. 9, no. 3-4, pp. 137-159, 2000.
31. C. Tomás-Zapico and A. Coto-Montes, "Aproposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes," Journal of Pineal Research, vol. 39, no. 2, pp. 99-104, 2005.
32. H. Tamura, A. Takasaki, I. Miwa et al., "Oxidative stress impairs oocyte quality andmelatonin protects oocytes fromfree radical damage and improves fertilization rate," Journal of Pineal Research, vol. 44, no. 3, pp. 280-287, 2008.
33. M. K. Kim, E. A. Park, H. J. Kim et al., "Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS?" Reproductive BioMedicine Online, vol. 26, no. 1, pp. 22-29, 2013.
34. S. Palini, S. Benedetti, M. C. Tagliamonte et al., "Influence of ovarian stimulation for IVF/ICSI on the antioxidant defence system and relationship to outcome," Reproductive BioMedicine Online, vol. 29, no. 1, pp. 65-71, 2014.
35. S. Fernando and L. Rombauts, "Melatonin: shedding light on infertility? A review of the recent literature," Journal of Ovarian Research, vol. 7, article 98, 2014.
36. T. Lord, B. Nixon, K. T. Jones, and R. J. Aitken, "Melatonin prevents postovulatory oocyte aging in the mouse and extends the window for optimal fertilization in vitro," Biology of Reproduction, vol. 88, no. 3, article 67, 2013.
37. J.-T. Kang, O.-J. Koo, D.-K. Kwon et al., "Effects of melatonin on in vitro maturation of porcine oocyte and expression of melatonin receptor RNA in cumulus and granulosa cells," Journal of Pineal Research, vol. 46, no. 1, pp. 22-28, 2009.
38. D. Wei, C. Zhang, J. Xie et al., "Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro," Journal of Assisted Reproduction and Genetics, vol. 30, no. 7, pp. 933-938, 2013.
39. A. S. Batioglu, U. U. Sahin, N. Ozturk, and E. Unsal, "The efficacy of melatonin administration on oocyte quality," Gynecological Endocrinology, vol. 28, pp. 91-93, 2012.
40. O. G. Eryilmaz, A. Devran, E. Sarikaya, F. N. Aksakal, L. Mollamahmutoglu, and N. Cicek, "Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems," Journal of Assisted Reproduction and Genetics, vol. 28, no. 9, pp. 815-820, 2011.
41. T. Nishihara, S. Hashimoto, K. Ito et al., "Oral melatonin supplementation improves oocyte and embryo quality in women undergoing in vitro fertilization-embryo transfer," Gynecological Endocrinology, vol. 30, no. 5, pp. 359-362, 2014.
42. G. Di Paolo and P. De Camilli, "Phosphoinositides in cell regulation and membrane dynamics," Nature, vol. 443, no. 7112, pp. 651-657, 2006.
43. J. Larner, "D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance," International Journal of Experimental Diabetes Research, vol. 3, no. 1, pp. 47-60, 2002.
44. 3 are blocked by a specific antibody to the type I receptor," Molecular Human Reproduction, vol. 8, no. 10, pp. 912-918, 2002.
45. L. M. Mehlmann and D. Kline, "Regulation of intracellular calciumin the mouse egg: calcium release in response to sperm or inositol trisphosphate is enhanced after meiotic maturation," Biology of Reproduction, vol. 51, no. 6, pp. 1088-1098, 1994.
46. J. J. Stachecki and D. R. Armant, "Transient release of calcium from inositol 1,4,5-triphosphate specific store, regulates mouse preimplantation development," Development, vol. 122, pp. 2485-2496, 1996.
47. 2+ releasemechanisms during oocyte maturation: A prelude to fertilization," Reviews of Reproduction, vol. 1, no. 3, pp. 137-143, 1996.
48. T. T. Y. Chiu, M. S. Rogers, E. L. K. Law, C. M. Briton-Jones, L. P. Cheung, and C. J. Haines, "Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality," Human Reproduction, vol. 17, no. 6, pp. 1591-1596, 2002.
49. T. T. Y. Chiu, M. S. Rogers, C. Briton-Jones, and C. Haines, "Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes," Human Reproduction, vol. 18, no. 2, pp. 408-416, 2003.
50. X. Shen, H. Xiao, R. Ranallo, W.-H. Wu, and C. Wu, "Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates," Science, vol. 299, no. 5603, pp. 112-114, 2003.
51. M. Falasca and T. Maffucci, "Rethinking phosphatidylinositol 3-monophosphate," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1793, no. 12, pp. 1795-1803, 2009.
52. M. J. Berridge and R. F. Irvine, "Inositol phosphates and cell signalling," Nature, vol. 341, no. 6239, pp. 197-205, 1989.
53. J. Larner, D. L. Brautigan, and M.O. Thorner, "D-chiro-inositol glycans in insulin signaling and insulin resistance," Molecular Medicine, vol. 16, no. 11-12, pp. 543-551, 2010.
54. J. Larner, L. C. Huang, C. F. W. Schwartz et al., "Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D-chiroinositol," Biochemical and Biophysical Research Communications, vol. 151, no. 3, pp. 1416-1426, 1988.
55. I. Asplin, G. Galasko, and J. Larner, "chiro-Inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, andmuscle of control and type II diabetic subjects," Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 5924-5928, 1993.
56. J. Larner and J. W. Craig, "Urinary myo-inositol-to-chiroinositol ratios and insulin resistance," Diabetes Care, vol. 19, no. 1, pp. 76-78, 1996.
57. J.-P. Baillargeon, E. Diamanti-Kandarakis, R. E. Ostlund Jr., T. Apridonidze, M. J. Iuorno, and J. E. Nestler, "Altered D-chiroinositol urinary clearance in women with polycystic ovary syndrome," Diabetes Care, vol. 29, no. 2, pp. 300-305, 2006.
58. J. E. Nestler, D. J. Jakubowicz, P. Reamer, R. D. Gunn, and G. Allan, "Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome," The New England Journal of Medicine, vol. 340, no. 17, pp. 1314-1320, 1999.
59. A. D. Genazzani, C. Lanzoni, F. Ricchieri, and V. M. Jasonni, "Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome," Gynecological Endocrinology, vol. 24, no. 3, pp. 139-144, 2008.
60. A. Pizzo, A. S. Laganà, and L. Barbaro, "Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS," Gynecological Endocrinology, vol. 30, no. 3, pp. 205-208, 2014.
61. S. Gerli, M. Mignosa, and G. C. Di Renzo, "Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial," European Review for Medical and Pharmacological Sciences, vol. 7, no. 6, pp. 151-159, 2003.
62. C. Paul, A. S. Laganà, P. Maniglio, O. Triolo, and D. M. Brady, "Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives," Gynecological Endocrinology, vol. 32, no. 6, pp. 431-438, 2016.
63. M. Nordio and E. Proietti, "The combined therapy with myoinositol and D-Chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared tomyo-inositol supplementation alone," European Review for Medical and Pharmacological Sciences, vol. 16, no. 5, pp. 575-581, 2012.
64. R. Isabella and E. Raffone, "Does ovary need D-chiro-inositol?" Journal of Ovarian Research, vol. 5, no. 1, article 14, 2012.
65. G. Carlomagno, V. Unfer, and S. Roseff, "The D-chiro-inositol paradox in the ovary," Fertility and Sterility, vol. 95, no. 8, pp. 2515-2516, 2011.
66. P. Holm, P. J. Booth, M. H. Schmidt, T. Greve, and H. Callesen, "High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serumproteins," Theriogenology, vol. 52, no. 4, pp. 683-700, 1999.
67. A. Pesty, B. Lefevre, J. Kubiak, G. Geraud, J. Tesarik, and B. Maro, "Mouse oocyte maturation is affected by lithium via the polyphosphoinositide metabolism and the microtubule network," Molecular Reproduction and Development, vol. 38, no. 2, pp. 187-199, 1994.
68. G. F. Brusco and M. Mariani, "Inositol: effects on oocyte quality in patients undergoing ICSI. An open study," European Review for Medical and Pharmacological Sciences, vol. 17, no. 22, pp. 3095-3102, 2013.
69. L. Ciotta, M. Stracquadanio, I. Pagano, A. Carbonaro, M. Palumbo, and F. Gulino, "Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial," European Review for Medical and Pharmacological Sciences, vol. 15, no. 5, pp. 509-514, 2011.
70. E. Papaleo, V. Unfer, J.-P. Baillargeon, F. Fusi, F. Occhi, and L. De Santis, "Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial," Fertility and Sterility, vol. 91, no. 5, pp. 1750-1754, 2009.
71. V. Unfer, G. Carlomagno, P. Rizzo, E. Raffone, and S. Roseff, "Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial," European Review for Medical and Pharmacological Sciences, vol. 15, no. 4, pp. 452-457, 2011.
72. S. Colazingari, M. Treglia, R. Najjar, and A. Bevilacqua, "The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results froma randomized controlled trial," Archives of Gynecology and Obstetrics, vol. 288, no. 6, pp. 1405-1411, 2013.
73. A. Pacchiarotti, G. Carlomagno, G. Antonini, and A. Pacchiarotti, "Effect of myo-inositol and melatonin versus myoinositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome," Gynecological Endocrinology, vol. 32, no. 1, pp. 69-73, 2016.
74. P. Rizzo, E. Raffone, and V. Benedetto, "Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial," European Review for Medical and Pharmacological Sciences, vol. 14, no. 6, pp. 555-561, 2010.
75. V. Unfer, E. Raffone, P. Rizzo, and S. Buffo, "Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study," Gynecological Endocrinology, vol. 27, no. 11, pp. 857-861, 2011.